These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29452288)

  • 1. Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia.
    Graber TG; Rawls BL; Tian B; Durham WJ; Brightwell CR; Brasier AR; Rasmussen BB; Fry CS
    Exp Gerontol; 2018 Jun; 106():88-100. PubMed ID: 29452288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cachexia decreases specific force and accelerates fatigue in limb muscle.
    Roberts BM; Frye GS; Ahn B; Ferreira LF; Judge AR
    Biochem Biophys Res Commun; 2013 Jun; 435(3):488-92. PubMed ID: 23673294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diaphragm and ventilatory dysfunction during cancer cachexia.
    Roberts BM; Ahn B; Smuder AJ; Al-Rajhi M; Gill LC; Beharry AW; Powers SK; Fuller DD; Ferreira LF; Judge AR
    FASEB J; 2013 Jul; 27(7):2600-10. PubMed ID: 23515443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voluntary exercise does not improve muscular properties or functional capacity during C26-induced cancer cachexia in mice.
    Hiroux C; Dalle S; Koppo K; Hespel P
    J Muscle Res Cell Motil; 2021 Jun; 42(2):169-181. PubMed ID: 33606189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
    White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.
    Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
    Dis Model Mech; 2012 Jul; 5(4):533-45. PubMed ID: 22563056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cachectic skeletal muscle response to a novel bout of low-frequency stimulation.
    Puppa MJ; Murphy EA; Fayad R; Hand GA; Carson JA
    J Appl Physiol (1985); 2014 Apr; 116(8):1078-87. PubMed ID: 24610533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms of cachexia underlying muscle dysfunction in COPD.
    Remels AH; Gosker HR; Langen RC; Schols AM
    J Appl Physiol (1985); 2013 May; 114(9):1253-62. PubMed ID: 23019314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cachexia and sarcopenia: mechanisms and potential targets for intervention.
    Argilés JM; Busquets S; Stemmler B; López-Soriano FJ
    Curr Opin Pharmacol; 2015 Jun; 22():100-6. PubMed ID: 25974750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle function during the progression of cancer cachexia in the male Apc
    VanderVeen BN; Hardee JP; Fix DK; Carson JA
    J Appl Physiol (1985); 2018 Mar; 124(3):684-695. PubMed ID: 29122966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological characterization of a mouse model of cachexia in colorectal liver metastases.
    Murphy KT; Struk A; Malcontenti-Wilson C; Christophi C; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(10):R854-64. PubMed ID: 23485871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGC1α overexpression preserves muscle mass and function in cisplatin-induced cachexia.
    Huot JR; Pin F; Chatterjee R; Bonetto A
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2480-2491. PubMed ID: 35903870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
    Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
    J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Toll-like receptor 3 increases mouse aortic vascular smooth muscle cell contractility through ERK1/2 pathway.
    Hardigan T; Spitler K; Matsumoto T; Carrillo-Sepulveda MA
    Pflugers Arch; 2015 Nov; 467(11):2375-85. PubMed ID: 25724934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 deficiency exacerbates frailty and sarcopenia by impairing skeletal muscle mitochondrial biogenesis and dynamics in an age-dependent manner.
    Huang DD; Fan SD; Chen XY; Yan XL; Zhang XZ; Ma BW; Yu DY; Xiao WY; Zhuang CL; Yu Z
    Exp Gerontol; 2019 May; 119():61-73. PubMed ID: 30690066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eccentric contraction-induced myofiber growth in tumor-bearing mice.
    Hardee JP; Mangum JE; Gao S; Sato S; Hetzler KL; Puppa MJ; Fix DK; Carson JA
    J Appl Physiol (1985); 2016 Jan; 120(1):29-37. PubMed ID: 26494443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MuRF1 or MuRF2 is essential for the induction of skeletal muscle atrophy and dysfunction in a murine pulmonary hypertension model.
    Nguyen T; Bowen TS; Augstein A; Schauer A; Gasch A; Linke A; Labeit S; Adams V
    Skelet Muscle; 2020 Apr; 10(1):12. PubMed ID: 32340625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer.
    Huot JR; Pin F; Essex AL; Bonetto A
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
    Saitoh M; Ishida J; Doehner W; von Haehling S; Anker MS; Coats AJS; Anker SD; Springer J
    Int J Cardiol; 2017 Jul; 238():5-11. PubMed ID: 28427849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.